Victory Capital Management
SRGA

Victory Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Victory Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-777
Closed -$4K – 2789
2022
Q1 		$4K Buy
777
+203
+35% +$3.08K ﹤0.01% 2715
2021
Q4 		$12K Sell
574
-19
-3% -$508 ﹤0.01% 2729
2021
Q3 		$19K Sell
593
-29
-5% -$1.06K ﹤0.01% 2731
2021
Q2 		$26K Buy
622
+143
+30% +$7.32K ﹤0.01% 2691
2021
Q1 		$31K Buy
+479
New +$33.4K ﹤0.01% 2701
2020
Q4 		– Sell
-8,878
Closed -$482K – 2600
2020
Q3 		$482K Sell
8,878
-4,289
-33% -$328K ﹤0.01% 1975
2020
Q2 		$1.26M Sell
13,167
-15,199
-54% -$1.13M ﹤0.01% 1621
2020
Q1 		$1.46M Buy
28,366
+11,643
+70% +$1.22M ﹤0.01% 1724
2019
Q4 		$1.38M Buy
16,723
+409
+3% +$28.7K ﹤0.01% 1644
2019
Q3 		$1.4M Buy
16,314
+649
+4% +$69.3K ﹤0.01% 1600
2019
Q2 		$2M Buy
15,665
+1,697
+12% +$244K ﹤0.01% 1139
2019
Q1 		$2.52M Buy
13,968
+2,470
+21% +$357K 0.01% 1040
2018
Q4 		$1.28M Buy
11,498
+96
+0.8% +$12.5K ﹤0.01% 1149
2018
Q3 		$1.54M Buy
11,402
+2,835
+33% +$391K ﹤0.01% 1162
2018
Q2 		$1.18M Buy
8,567
+81
+1% +$11.1K ﹤0.01% 1208
2018
Q1 		$1.17M Hold
8,486
– – ﹤0.01% 1208
2017
Q4 		$1.04M Buy
8,486
+1,608
+23% +$221K ﹤0.01% 1217
2017
Q3 		$939K Sell
6,878
-474
-6% -$71.6K ﹤0.01% 1223
2017
Q2 		$1.29M Buy
7,352
+76
+1% +$10.8K ﹤0.01% 1114
2017
Q1 		$873K Sell
7,276
-1,438
-17% -$150K ﹤0.01% 1206
2016
Q4 		$850K Buy
8,714
+3,225
+59% +$296K ﹤0.01% 1172
2016
Q3 		$515K Sell
5,489
-414
-7% -$41.5K ﹤0.01% 1244
2016
Q2 		$636K Hold
5,903
– – ﹤0.01% 966
2016
Q1 		$709K Sell
5,903
-390
-6% -$41K ﹤0.01% 940
2015
Q4 		$749K Buy
6,293
+863
+16% +$111K ﹤0.01% 916
2015
Q3 		$925K Sell
5,430
-2,602
-32% -$499K ﹤0.01% 741
2015
Q2 		$1.56M Hold
8,032
– – 0.01% 671
2015
Q1 		$1.19M Sell
8,032
-289
-3% -$44K ﹤0.01% 624
2014
Q4 		$1.3M Buy
+8,321
New +$1.2M ﹤0.01% 638

Other funds holding SRGA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management's SRGA Position: Q2 2022 in Review

Victory Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2022, closing a stake of 777 shares — an estimated $4K sold.

Victory Capital Management first reported a position in SRGA in Q4 2014 and held it in 29 quarters. The position peaked at $2.52M in Q1 2019. 40 funds tracked by Wall St. Rank hold SRGA as of Q2 2022.

  • Victory Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Victory Capital Management sold 777 Surgalign Holdings, Inc. Common Stock shares in Q2 2022, an estimated $4K.
  • Victory Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2014 and held it in 29 quarters.
  • Victory Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $2.52M in Q1 2019.
  • 40 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.